Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery.

Eudragit® L 100-55 nanofibers loaded with diclofenac sodium (DS) were successfully prepared using an electrospinning process, and characterized for structural and pharmacodynamic properties. The influence of solvent and drug content on fiber formation and quality was also investigated. Fiber formation was successful using a solvent mixture 5:1 (v/v) ethanol:DMAc. XRD and DSC analysis of fibers confirm electron microscopic evidence that DS is evenly distributed in the nanofibers in an amorphous state. FTIR analysis indicates hydrogen bonding occurs between the drug and the polymer, which accounts for the molecular integration of the two components. In vitro dissolution tests verified that all the drug-loaded Eudragit® L 100-55 nanofibers had pH-dependent drug release profiles, with limited, less than 3%, release at pH 1.0, but a sustained and complete release at pH 6.8. This profile of properties indicates drug-loaded Eudragit® L 100-55 nanofibers have the potential to be developed as oral colon-targeted drug delivery systems.

[1]  C. Branford-White,et al.  Third generation solid dispersions of ferulic acid in electrospun composite nanofibers. , 2010, International journal of pharmaceutics.

[2]  J. Nie,et al.  Electrospun Core−Shell Structure Nanofibers from Homogeneous Solution of Poly(ethylene oxide)/Chitosan , 2009 .

[3]  Shaobing Zhou,et al.  Release modulation and cytotoxicity of hydroxycamptothecin-loaded electrospun fibers with 2-hydroxypropyl-beta-cyclodextrin inoculations. , 2010, International journal of pharmaceutics.

[4]  M. Natu,et al.  Effects of drug solubility, state and loading on controlled release in bicomponent electrospun fibers. , 2010, International journal of pharmaceutics.

[5]  Yen Wei,et al.  Electrospinning of Cellulose-Based Fibers From NaOH/Urea Aqueous System , 2010 .

[6]  Deng-Guang Yu,et al.  An elevated temperature electrospinning process for preparing acyclovir-loaded PAN ultrafine fibers , 2010 .

[7]  C. Branford-White,et al.  Coaxial electrospinning with organic solvent for controlling the size of self-assembled nanoparticles. , 2011, Chemical communications.

[8]  J. Nie,et al.  Effects of solution properties and electric field on the electrospinning of hyaluronic acid , 2011 .

[9]  Y. Kadioglu,et al.  Formulation and In vitro Characterization of Eudragit® L100 and Eudragit® L100-PLGA Nanoparticles Containing Diclofenac Sodium , 2010, AAPS PharmSciTech.

[10]  C. Branford-White,et al.  Electrospun nanofiber-based drug delivery systems , 2009 .

[11]  The Compatibility of Acyclovir with Polyacrylonitrile in the Electrospun Drug-Loaded Nanofibers , 2010 .

[12]  Kam W Leong,et al.  Sustained release of proteins from electrospun biodegradable fibers. , 2005, Biomacromolecules.

[13]  K. Sawicka,et al.  Electrospun biocomposite nanofibers for urea biosensing , 2005 .

[14]  M. Maghsoodi Physicomechanical Properties of Naproxen-Loaded Microparticles Prepared from Eudragit L100 , 2009, AAPS PharmSciTech.

[15]  R. I. Moustafine,et al.  Physicochemical characterization and drug release properties of Eudragit E PO/Eudragit L 100-55 interpolyelectrolyte complexes. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  Andreas Greiner,et al.  Electrospinning: a fascinating method for the preparation of ultrathin fibers. , 2007, Angewandte Chemie.

[17]  John Layman,et al.  Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Sudesh Kumar Yadav,et al.  Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.

[19]  E. Merisko-Liversidge,et al.  Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds , 2008, Toxicologic pathology.

[20]  H. Onishi,et al.  Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis. , 2008, International journal of pharmaceutics.

[21]  N. Peppas,et al.  Preparation of poly(methacrylic acid-g-poly(ethylene glycol)) nanospheres from methacrylic monomers for pharmaceutical applications. , 2002, International journal of pharmaceutics.

[22]  G. Bowlin,et al.  Cross-linking methods of electrospun fibrinogen scaffolds for tissue engineering applications , 2008, Biomedical materials.

[23]  Yen Wei,et al.  One-dimensional composite nanomaterials: synthesis by electrospinning and their applications. , 2009, Small.

[24]  John Baldoni,et al.  Electrospun Nanofibers in Oral Drug Delivery , 2010, Pharmaceutical Research.

[25]  N. Peppas Analysis of Fickian and non-Fickian drug release from polymers. , 1985, Pharmaceutica acta Helvetiae.

[26]  Hongliang Jiang,et al.  Encapsulation and controlled release of lysozyme from electrospun poly(ε-caprolactone)/poly(ethylene glycol) non-woven membranes by formation of lysozyme–oleate complexes , 2008, Journal of materials science. Materials in medicine.

[27]  Itziar Silva,et al.  Physical blends of starch graft copolymers as matrices for colon targeting drug delivery systems , 2009 .

[28]  Bhupender S. Gupta,et al.  Co‐axial Electrospinning for Nanofiber Structures: Preparation and Applications , 2008 .

[29]  R. Poppi,et al.  Direct determination of diclofenac in pharmaceutical formulations containing B vitamins by using UV spectrophotometry and partial least squares regression. , 2004, Journal of pharmaceutical and biomedical analysis.

[30]  Gregory C Rutledge,et al.  Formation of fibers by electrospinning. , 2007, Advanced drug delivery reviews.

[31]  Andreas Greiner,et al.  Electrospun biodegradable nanofiber nonwovens for controlled release of proteins. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[32]  A. Nokhodchi,et al.  Development of pH-sensitive Insulin Nanoparticles using Eudragit L100-55 and Chitosan with Different Molecular Weights , 2010, AAPS PharmSciTech.

[33]  X. Mo,et al.  Intermolecular interactions in electrospun collagen–chitosan complex nanofibers , 2008 .

[34]  Joachim Kohn,et al.  Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing. , 2008, International journal of pharmaceutics.

[35]  C. Branford-White,et al.  Ester prodrug-loaded electrospun cellulose acetate fiber mats as transdermal drug delivery systems , 2010, Journal of materials science. Materials in medicine.

[36]  Deng-Guang Yu,et al.  Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers , 2009, Nanotechnology.

[37]  B. Ding,et al.  Polyoxometalate nanotubes from layer-by-layer coating and thermal removal of electrospun nanofibres , 2005 .

[38]  Kam W Leong,et al.  Engineering strategies to enhance nanoparticle-mediated oral delivery , 2008, Journal of biomaterials science. Polymer edition.

[39]  P. Vavia,et al.  Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[40]  Aditya Mohan Kaushal,et al.  Amorphous drug delivery systems: molecular aspects, design, and performance. , 2004, Critical reviews in therapeutic drug carrier systems.

[41]  Cato T Laurencin,et al.  Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.

[42]  J. Mitchell,et al.  Influence of plasma protein on the potencies of inhibitors of cyclooxygenase‐1 and ‐2 , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  Yang Wang,et al.  Electrospun Nanofibrous Membranes: A Novel Solid Substrate for Microfluidic Immunoassays for HIV , 2008 .

[44]  Alan B. Watts,et al.  Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55. , 2009, International journal of pharmaceutics.

[45]  P. Supaphol,et al.  Electrospinning of methacrylate‐based copolymers: Effects of solution concentration and applied electrical potential on morphological appearance of as‐spun fibers , 2005 .

[46]  A. Florence,et al.  Release of DNA from dendriplexes encapsulated in PLGA nanoparticles. , 2005, International journal of pharmaceutics.

[47]  Hadi Valizadeh,et al.  Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[48]  C. Branford-White,et al.  Multicomponent Amorphous Nanofibers Electrospun from Hot Aqueous Solutions of a Poorly Soluble Drug , 2010, Pharmaceutical Research.

[49]  Yuquan Wei,et al.  Synthesis and characterization of poly(methoxyl ethylene glycol-caprolactone-co-methacrylic acid-co-poly(ethylene glycol) methyl ether methacrylate) pH-sensitive hydrogel for delivery of dexamethasone. , 2010, International journal of pharmaceutics.

[50]  Horst A von Recum,et al.  Electrospinning: applications in drug delivery and tissue engineering. , 2008, Biomaterials.